Depression and pregnancy: Use of selective serotonin reuptake inhibitors in pregnancy

Primary Care Update for Ob/Gyns

Volumn 5, Issue 1, 1998, Pages 11-15

  McConnell, Peter J ^a   Linn, Kathy ^a   Filkins, Karen ^a  

^a WESTERN PENNSYLVANIA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; BIRTH DEFECT; BIRTH WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; FEMALE; HUMAN; INTERVIEW; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION;

EID: 0031919732     PISSN: 1068607X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1068-607X(97)00116-9     Document Type: Review

References (14)

1. 1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51: 8-19.
2. 2. Yonkers KA, Chantilis SJ, Recognition of depression in obstetric/gynecology practices. Am J Obstet Gynecol 1995;173:632-8.
3. 3. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression. J Clin Psychiatry 1993;54:405-18.
4. 4. Rothschild AJ. Advances in the management of depression: implications for the obstetrician/gynecologist. Am J Obstet Gynecol 1995; 173:659-66.
5. 5. Nora JJ, Nora AH, Toews WH. Lithium, Ebstein's anomaly, and other congenital heart defects. Lancet 1974;2:594-5.
6. 6. Elia J, Katz IR, Simpson GM. Teratogenicity of psychotherapeutic medications. Psychopharmacol Bull 1987; 23:531-79.
7. 7. Weinstein MR, Goldfield MD. Cardiovascular malformations with lithium use during pregnancy. Am J Psychiatry 1975;132:529-31.
8. 8. Beaumont G. The toxicity of antidepressants. Br J Psychiatry 1989; 154:454-8.
9. 9. Callahan M, Kassel D. Epidemiology of fatal tricyclic antidepressant ingestion: implications for management. Ann Emerg Med 1985;14:1-9.
10. 10. Kulig K. Management of poisoning associated with "newer" antidepressant agents. Ann Emerg Med 1986;15:1039-45.
11. 11. Goldstein DJ, Marvel DE. Psychotropic medications during pregnancy: risk to the fetus. JAMA 1993; 270:2177.
12. 12. Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinelli M, Sihn S, et al. Pregnancy outcome following first trimester exposure to fluoxetine. JAMA 1993;269:2246-8.
13. 13. Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335: 1010-5.
14. 14. Robert E. Treatment depression in pregnancy [editorial; comment]. N Engl J Med 1996;335:1056-8.